NEW YORK (Reuters Health) – Prasugrel helps stop thrombotic events in patients who undergo percutaneous coronary intervention (PCI), but associated “nuisance” bleeding may prompt discontinuation of such therapy,…
NEW YORK (Reuters Health) – Percutaneous edge-to-edge mitral valve repair using the MitraClip device can be safely performed even in very high risk patients, researchers from Germany report…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
NEW YORK (Reuters Health) – The early use of nasal continuous positive airway pressure (nCPAP) reduces the number of preterm babies who are intubated and given surfactant. In…
NEW YORK (Reuters Health) – A small randomized study found no therapeutic advantage to high-dose vitamin D2 supplementation over and above ongoing low-dose vitamin D2 supplementation in patients…
NEW YORK (Reuters Health) – Testing for autoantibody against the 155-kDa protein is a “highly accurate” tool for diagnosing cancer-associated myositis in adults with dermatomyositis, according to a…
NEW YORK (Reuters Health) – The Oncotype DX test, based on reverse transcription polymerase chain reaction (RT-PCR), for HER2 gene amplification in breast cancers has an “unacceptable” false-negative…
NEW YORK (Reuters Health) – Therapy aimed at reducing levels of amino-terminal pro–B-type natriuretic peptide (NT-proBNP) in patients with chronic heart failure (HF) is more beneficial than standard…
NEW YORK (Reuters Health) – In children having surgery, isotonic parenteral maintenance fluids (PMS) are safer than hypotonic PMS in guarding against postoperative hyponatremia, with six the number…
